Home
Venrock Healthcare Capital Partners III reported a 8.3% stake in Jade Biosciences JBIO · 5,145,330 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 8.3%
- Last report
- 9.9% · filed 26/02/17
- Shares held
- 5,145,330 sh
- Class
- Common Stock, $0.0001 par value
- Event date
- 26/06/30
- Filed
- 26/08/14
8.3% stake · −1.6pp from the last report
- Stake
- 8.3%
- Last report
- 9.9%
- Since last report
- −1.6pp
Jade Biosciences trades, last 26 weeks
What else happened in Jade Biosciences around then
Filed or reported within 30 days of the trade day · 05/31~07/30Venrock Healthcare Capital Partners III's other 5% stake reports
- Venrock Healthcare Capital Partners III
5% stakeX4 Pharmaceuticals
5% stakeX4 Pharmaceuticals
XFOR
5.6% stake
5,555,047 sh
5.6% stake
Filed 09/21
- Venrock Healthcare Capital Partners III
5% stakeKorsana Biosciences
5% stakeKorsana Biosciences
KRSA
9.9% stake
4,552,277 sh
9.9% stake
Filed 09/15
- Venrock Healthcare Capital Partners III
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
4.7% stake
1,574,892 sh
4.7% stake
Filed 08/14
- Venrock Healthcare Capital Partners III
5% stakeOruka Therapeutics
5% stakeOruka Therapeutics
ORKA
7.4% stake
4,556,952 sh
7.4% stake
Filed 08/14
- Venrock Healthcare Capital Partners III
5% stakeenGene Therapeutics
5% stakeenGene Therapeutics
ENGN
0% stake
0 sh
0% stake
Filed 08/14
